|
US3336199A
(en)
*
|
1963-07-03 |
1967-08-15 |
Warner Lambert Pharmaceutical |
Tablet composition
|
|
US3395211A
(en)
*
|
1965-12-10 |
1968-07-30 |
Carter Wallace |
Tableting process
|
|
US3725556A
(en)
*
|
1970-11-12 |
1973-04-03 |
D Hanssen |
Method of manufacturing rapidly disintegrating pharmaceutical tablets
|
|
US3885027A
(en)
*
|
1971-04-12 |
1975-05-20 |
West Laboratories Inc |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
|
US3671633A
(en)
*
|
1971-05-10 |
1972-06-20 |
American Cyanamid Co |
Process for tabletting acetazolamide
|
|
US3900569A
(en)
*
|
1971-09-30 |
1975-08-19 |
Sucrest Corp |
Direct compression vehicle
|
|
US3987204A
(en)
*
|
1972-09-15 |
1976-10-19 |
Sucrest Corporation |
Direct compression vehicle
|
|
US5066441A
(en)
*
|
1980-12-12 |
1991-11-19 |
Rhone-Poulenc Basic Chemicals Co. |
Process for compacting a calcium phosphate composition
|
|
US4517179A
(en)
*
|
1983-04-29 |
1985-05-14 |
Pennwalt Corporation |
Rapid dissolving, uniform drug compositions and their preparation
|
|
DE3515695C2
(de)
*
|
1985-05-02 |
1987-03-05 |
Benckiser-Knapsack Gmbh, 6802 Ladenburg |
Verfahren zur Herstellung von grobkörnigem Dicalciumphosphat-Dihydrat
|
|
US4675188A
(en)
*
|
1985-08-02 |
1987-06-23 |
Stauffer Chemical Company |
Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
|
|
US4707361A
(en)
*
|
1985-08-02 |
1987-11-17 |
Stauffer Chemical Company |
Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
|
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
|
US6080428A
(en)
*
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
|
EP1128817A1
(fr)
*
|
1998-10-27 |
2001-09-05 |
Biovail Technologies Ltd |
Microparticules contenant du peg et/ou des esters glyceriliques de peg
|
|
NZ535261A
(en)
*
|
2000-08-08 |
2004-12-24 |
Smithkline Beecham P |
A tablet comprising the hydrochloride salt of N-(1-nbutyl-4-piperidinyl)methyl]-3,4-[1,3]oxazino[3,2-a] indole-10-carboxamide
|
|
ATE329581T1
(de)
*
|
2002-02-14 |
2006-07-15 |
Glaxo Group Ltd |
Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
|
|
WO2005107722A2
(fr)
*
|
2004-05-04 |
2005-11-17 |
Rhodia Inc. |
Phosphate tricalcique directement compressible
|
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
|
EP2228368A1
(fr)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-ph2nyl2thoxy)hexyl]amino}-1-hydroxy2thyl)-8-hydroxyquinolin-2(1h)-one
|
|
JP5753842B2
(ja)
*
|
2009-07-10 |
2015-07-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
水分含量の低い打錠補助剤およびその調製方法
|
|
US8834945B2
(en)
|
2010-01-15 |
2014-09-16 |
Mos Holdings Inc. |
Granulated phosphate product containing abrasivity and lubricity additives
|
|
TW201141387A
(en)
*
|
2010-01-15 |
2011-12-01 |
Mosaic Co |
Granulated monocalcium phosphate product containing abrasivity and lubricity additives
|
|
EP2578570A1
(fr)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
|
|
AR095245A1
(es)
|
2013-03-11 |
2015-09-30 |
Mos Holdings Inc |
Composición alimenticia granulada de fosfato que contiene enzimas
|
|
WO2014160064A1
(fr)
*
|
2013-03-14 |
2014-10-02 |
Ocean Spray Cranberries, Inc. |
Procédés et produits d'agent d'écoulement
|